Extended D3 Mesenterectomy in Small Bowel Cancer Treatment: Feasibility and Importance for Staging. First Results of a Prospective Clinical Trial
Erik Kjæstad, Espen Thiis‐Evensen, Bjørn Edwin, Arne Olav Bakka, Anne Helene Lilleaas, Yngve Thorsen, Johannes Kurt Schultz · 2026
Read Extended D3 Mesenterectomy in Small Bowel Cancer Treatment: Feasibility and Importance for Staging. First Results of a Prospective Clinical Trial by Erik Kjæstad, Espen Thiis‐Evensen, Bjørn Edwin, Arne Olav Bakka, Anne Helene Lilleaas, Yngve Thorsen, Johannes Kurt Schultz (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13662501.txt.
Description
Erik Kjæstad and co-authors report first results from a trial of extended lymph node removal in small bowel cancer surgery. Their 2026 paper notes that surgical practice for this cancer lacks consensus, above all on how much node-bearing tissue to take. Clearing central nodes can be hard when tumors scar the tissue around major gut vessels.
Their technique removes the tissue in front of and behind those vessels up to the root of the mesentery. Three-dimensional maps of each patient's vessels guided the surgery. Most enrolled patients received the full extended clearance, with either small bowel or combined resections. The team also built a new classification for resections. Feasibility plus better staging is the claim this first report tests.
Catalog record
| CREATOR | Erik Kjæstad, Espen Thiis‐Evensen, Bjørn Edwin, Arne Olav Bakka, Anne Helene Lilleaas, Yngve Thorsen, Johannes Kurt Schultz |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 32 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |